298 related articles for article (PubMed ID: 35346200)
41. Serum M2-pyruvate kinase: A promising non-invasive biomarker for colorectal cancer mass screening.
Meng W; Zhu HH; Xu ZF; Cai SR; Dong Q; Pan QR; Zheng S; Zhang SZ
World J Gastrointest Oncol; 2012 Jun; 4(6):145-51. PubMed ID: 22737276
[TBL] [Abstract][Full Text] [Related]
42. The Ratio of CD86+/CD163+ Macrophages Predicts Postoperative Recurrence in Stage II-III Colorectal Cancer.
Xu G; Jiang L; Ye C; Qin G; Luo Z; Mo Y; Chen J
Front Immunol; 2021; 12():724429. PubMed ID: 34512652
[TBL] [Abstract][Full Text] [Related]
43. Prognostic Value of C-Reactive Protein, Glasgow Prognostic Score, and C-Reactive Protein-to-Albumin Ratio in Colorectal Cancer.
Zhou J; Wei W; Hou H; Ning S; Li J; Huang B; Liu K; Zhang L
Front Cell Dev Biol; 2021; 9():637650. PubMed ID: 34765598
[No Abstract] [Full Text] [Related]
44. CT-Based Radiomics Signature: A Potential Biomarker for Predicting Postoperative Recurrence Risk in Stage II Colorectal Cancer.
Fan S; Cui X; Liu C; Li X; Zheng L; Song Q; Qi J; Ma W; Ye Z
Front Oncol; 2021; 11():644933. PubMed ID: 33816297
[No Abstract] [Full Text] [Related]
45. Efficacy of Adjuvant Chemotherapy According to the Classification of Recurrence Risk Based on Systemic Inflammatory Markers in Patients With Liver Metastases of Colorectal Cancer.
Shibutani M; Nagahara H; Fukuoka T; Iseki Y; Hirakawa K; Ohira M
Anticancer Res; 2019 Sep; 39(9):5039-5045. PubMed ID: 31519612
[TBL] [Abstract][Full Text] [Related]
46. Pretreatment albumin/fibrinogen ratio as a promising predictor for the survival of advanced non small-cell lung cancer patients undergoing first-line platinum-based chemotherapy.
Ying J; Zhou D; Gu T; Huang J; Liu H
BMC Cancer; 2019 Mar; 19(1):288. PubMed ID: 30925910
[TBL] [Abstract][Full Text] [Related]
47. Combination of preoperative NLR, PLR and CEA could increase the diagnostic efficacy for I-III stage CRC.
Peng HX; Yang L; He BS; Pan YQ; Ying HQ; Sun HL; Lin K; Hu XX; Xu T; Wang SK
J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27686880
[TBL] [Abstract][Full Text] [Related]
48. A Prospective Study of Comparing Multi-Gene Biomarker Chip and Serum Carcinoembryonic Antigen in the Postoperative Surveillance for Patients with Stage I-III Colorectal Cancer.
Chang YT; Huang MY; Yeh YS; Huang CW; Tsai HL; Cheng TL; Wang JY
PLoS One; 2016; 11(10):e0163264. PubMed ID: 27701415
[TBL] [Abstract][Full Text] [Related]
49. Early detection of colorectal cancer based on circular DNA and common clinical detection indicators.
Li J; Jiang T; Ren ZC; Wang ZL; Zhang PJ; Xiang GA
World J Gastrointest Surg; 2022 Aug; 14(8):833-848. PubMed ID: 36157359
[TBL] [Abstract][Full Text] [Related]
50. Diagnostic value of matrix metalloproteinases 2, 7 and 9 in urine for early detection of colorectal cancer.
Peng L; Zhang X; Zhang ML; Jiang T; Zhang PJ
World J Gastrointest Surg; 2023 May; 15(5):931-939. PubMed ID: 37342853
[TBL] [Abstract][Full Text] [Related]
51. Prognostic significance of pre-resection albumin/fibrinogen ratio in patients with non-small cell lung cancer: A propensity score matching analysis.
Chen S; Yan H; Du J; Li J; Shen B; Ying H; Zhang Y; Chen S
Clin Chim Acta; 2018 Jul; 482():203-208. PubMed ID: 29653085
[TBL] [Abstract][Full Text] [Related]
52. Fecal CEA Has an Advantage in the Diagnosis of Colorectal Cancer at Early Stage.
Li L; Xing S; Wu M; Ao Y; Zheng X; Cai R; Han R; Li J; Li X; Zeng Q
Cancer Control; 2021; 28():10732748211048292. PubMed ID: 34615391
[TBL] [Abstract][Full Text] [Related]
53. Identification of serum miR-30a-5p as a diagnostic and prognostic biomarker in colorectal cancer.
Sun Y; Yang B; Lin M; Yu H; Chen H; Zhang Z
Cancer Biomark; 2019; 24(3):299-305. PubMed ID: 30829615
[TBL] [Abstract][Full Text] [Related]
54. Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection.
Abe S; Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Watanabe T
J Surg Res; 2016 Oct; 205(2):384-392. PubMed ID: 27664887
[TBL] [Abstract][Full Text] [Related]
55. The impact of chemotherapy-associated neutrophil/ lymphocyte counts on prognosis of adjuvant chemotherapy in colorectal cancer.
Chu-Yuan H; Jing P; Yi-Sheng W; He-Ping P; Hui Y; Chu-Xiong Z; Guo-Jian L; Guo-Qiang W
BMC Cancer; 2013 Apr; 13():177. PubMed ID: 23551939
[TBL] [Abstract][Full Text] [Related]
56. Preoperative fibrinogen to prealbumin ratio as a novel predictor for clinical outcome of hepatocellular carcinoma.
Zhang L; Chen QG; Li SQ; Zhang J; Min QH; Gao QF; Sun F; Jiang YH; Wang XZ; Ying HQ
Future Oncol; 2019 Jan; 15(1):13-22. PubMed ID: 30139267
[TBL] [Abstract][Full Text] [Related]
57. Real-world Data for High-risk Stage II Colorectal Cancer - The Role of Tumor Side in the Adjuvant Setting.
Araujo CS; Venchiarutti Moniz CM; Bonadio RC; Watarai GY; Rojas J; Nogueira PVS; Martinez JK; Moraes PMG; Braghiroli MI; Sabbaga J; Hoff PM
Clin Colorectal Cancer; 2021 Jun; 20(2):e100-e108. PubMed ID: 33234431
[TBL] [Abstract][Full Text] [Related]
58. The Prognostic Significance of Postoperative Adjuvant Chemotherapy in the Population Aged 75 Years and Older with Stage II-III Colorectal Cancer: A Retrospective Multi-Center Cohort Study.
Liu L; Pang X; Zhao K; Chen Y; Li Y; You R; Xu T; Liu M; Wu L; Li Z; Pu H
Int J Gen Med; 2023; 16():3311-3322. PubMed ID: 37554705
[TBL] [Abstract][Full Text] [Related]
59. Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer.
Abdel Ghafar MT; Gharib F; Abdel-Salam S; Elkhouly RA; Elshora A; Shalaby KH; El-Guindy D; El-Rashidy MA; Soliman NA; Abu-Elenin MM; Allam AA
Mol Biol Rep; 2020 Apr; 47(4):2509-2519. PubMed ID: 32088817
[TBL] [Abstract][Full Text] [Related]
60. Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer.
Yang XQ; Chen C; Wang FB; Peng CW; Li Y
Asian Pac J Cancer Prev; 2011; 12(5):1251-6. PubMed ID: 21875276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
